Resistance enzyme inhibitors

Our products prevent bacterial enzymes from destroying antibiotics

Our inhibitors target beta-lactamases not covered by inhibitors on the market

Technology:
  • Antimicrobial compound/strategy
  • Infection prevention
  • Antimicrobial stewardship
  • Microbial diagnostics
  • Removal antibiotics/bacteria

Microorganisms:
  • Bacteria
  • Viruses
  • Fungi
  • Yeasts
  • Parasites

Application:
  • Human
  • Veterinary
  • AgriFood
  • Environmental
  • Other

Development stage:
  • Development
  • Research
  • Validation
  • Market entry
  • Marketed product

Organization:
  • Company
  • Academia
  • Institute
  • NGO
  • Government

Partnering:
  • License
  • Co-develop
  • Joint Venture
  • Outsource
  • Sell

Funding organisation:
  • OTHER / NA
  • CARB-X
  • FIND
  • GARDP
  • REPAIR

Infectious disease area:
  • UTI
  • BSI
  • IAI
  • STI
  • RTI
  • GII
  • SSTI
  • CNSI
  • SSI

Geographic origin:
  • Eurasia
  • North America
  • South America
  • Africa
  • Oceania


A partner must contribute with competence and funding for late-stage clinical development. A partner may also be distributor in certain markets.

Adjutec is a biotech company developing beta-lactamase inhibitor to overcome the alarming increase in antimicrobial resistance.

Adjutec is supporting academic research in the field of new antibiotics


What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed